MARKET

VYGR

VYGR

Voyager Therapeutics Inc
NASDAQ
1.730
+0.030
+1.76%
After Hours: 1.760 +0.03 +1.73% 19:30 11/13 EST
OPEN
1.700
PREV CLOSE
1.700
HIGH
1.735
LOW
1.585
VOLUME
806.63K
TURNOVER
--
52 WEEK HIGH
5.48
52 WEEK LOW
1.585
MARKET CAP
107.66M
P/E (TTM)
-0.9951
1D
5D
1M
3M
1Y
5Y
1D
Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Voyager Therapeutics (VYGR)
TipRanks · 2d ago
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Voyager Therapeutics (VYGR)
TipRanks · 6d ago
Analysts’ Top Healthcare Picks: Voyager Therapeutics (VYGR), Evolent Health (EVH)
TipRanks · 6d ago
Weekly Report: what happened at VYGR last week (1102-1106)?
Weekly Report · 6d ago
Voyager Therapeutics price target lowered to $12 from $18 at Baird
TipRanks · 11/06 11:51
Voyager Therapeutics Reports Third Quarter 2026 Financial Results and $132 Million Cash Position
NASDAQ · 11/06 09:08
Voyager Therapeutics GAAP EPS of -$0.40 beats by $0.02, revenue of $4.01M misses by $2.34M
Seeking Alpha · 11/05 22:22
*Voyager Therapeutics 3Q Loss/Shr 40c >VYGR
Dow Jones · 11/05 21:01
More
About VYGR
Voyager Therapeutics, Inc. is a biotechnology company engaged in leveraging the power of human genetics to modify the course of neurological diseases. The Company’s pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of its programs are derived from its Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER) adeno-associated virus (AAV) capsid discovery platform, which is used to generate capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs includes Anti-Tau Antibody (VY7523), Tau Silencing Gene Therapy (VY1706), SOD1 Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program and others.

Webull offers Voyager Therapeutics Inc stock information, including NASDAQ: VYGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYGR stock methods without spending real money on the virtual paper trading platform.